Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Both vehicle types have fee trade-offs. This guide shows how expense ratios and additional costs stack up to help you pick the cheaper option.
28,162 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Insider stock moves can be alarming, but they aren’t always a red flag. This guide explains how to read a fastly stoc...
When a celebrity unveils a dramatic look, it often ripples into everyday spending. This article explores kardashian d...
A Manhattan class-action accuses Gemini of misrepresenting its growth plan during its September IPO. Shares have fall...
Analysts see a wall street pros upside for Royal Caribbean as 2026 capacity and earnings guidance point to a stronger...
ARMLS moves to an independent board with an advisory council to keep practitioner voices in governance. The transitio...
Super Micro Computer beat expectations on adjusted earnings and guided higher for Q4 revenue, while unveiling a nucle...
Tesla isn’t just selling cars—it's building an autonomy and energy ecosystem. This piece examines whether tesla: wall...
A major investor disclosed a $46 million stake in a Goldman Sachs BDC, signaling selective confidence in a sector fac...
Broker Public Portal and Realtors Property Resource unveiled a staged integration of the Realtors Valuation Model int...
March 2026 BEA data shows u.s. consumer spending tops $21.86 trillion, underscoring broad demand. A select group of f...
A landmark analysis of Swedish twins suggests genetics may influence about 45% of how people invest, from trading fre...